BMBL
Bumble Inc.
BMBL trails on the overall score without a compensating advantage in the available component scores.
SNDK
Sandisk Corporation
SNDK has the edge over BMBL overall, supported by stronger fundamentals.
BMBL Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Strong | |
| Healthy |
BMBL's cash flow and balance sheet are currently healthy, but its revenue and profitability are under pressure.
SNDK Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
SNDK's revenue, profitability, cash flow and balance sheet are all currently strong.
BMBL PE Valuation
BMBL has no meaningful PE right now: it lost money over the past year.
SNDK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 3.8x | $937 | — |
| Current | 7.5x | $937 | — |
| Cheap | 17x | $2,173 | +132% |
| Fair | 24x | $3,048 | +225% |
| Expensive | 59x | $7,452 | +695% |
Historical ranges are pointers, not guarantees.
SNDK's PE is 7.5x, but its earnings don't support one, so it isn't a reliable read right now.
BMBL Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong decline | |
| Decline | |
| Strongly weakening | |
| Limited | |
| Low |
Analysts expect BMBL's earnings and revenue to decline, with profitability weakening. However, they disagree widely on these estimates.
SNDK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| High |
SNDK has the edge over BMBL on the outlook, with more favorable earnings and revenue expectations.
BMBL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.63 | — |
| Q3 2026 | -$4.26 | -$2.36 |
| Q2 2026 | -$4.13 | +$3.21 |
| Q1 2026 | -$5.74 | -$1.07 |
| Q4 2025 | -$5.95 | -$1.34 |
| Q3 2025 | -$1.90 | +$2.99 |
| Q2 2025 | -$7.34 | -2259% |
| Q1 2025 | -$4.67 | -2847% |
| Q4 2024 | -$4.61 | -$4.58 |
BMBL is still losing money, but less than at its worst: $4.26 per share over the past year, against $7.34 at its worst in mid-2025.
SNDK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $247.30 | +97% |
| Q3 2026 | $125.61 | +$137.63 |
| Q2 2026 | $73.76 | +$85.07 |
| Q2 2025 | -$11.31 | -$6.65 |
SNDK has the edge over BMBL in the latest year-over-year earnings comparison.
BMBL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $207.1M | -16% |
| Q2 2026 | $210.5M | -15% |
| Q1 2026 | $212.4M | -14% |
| Q4 2025 | $224.2M | -14% |
| Q3 2025 | $246.2M | -10% |
| Q2 2025 | $248.2M | -7.6% |
| Q1 2025 | $247.1M | -7.7% |
| Q4 2024 | $261.6M | -4.4% |
BMBL's revenue has slid since its 2023 peak: $207M last quarter, down 16% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 26% | +0.5 points |
| Q2 2026 | -53% | +83 points |
| Q1 2026 | 31% | +13 points |
| Q4 2025 | -257% | -271 points |
| Q3 2025 | 26% | +332 points |
| Q2 2025 | -136% | -156 points |
| Q1 2025 | 18% | -0.1 points |
| Q4 2024 | 14% | +17 points |
BMBL's operating margin was 26% last quarter, about level with the same quarter a year ago, near the top of its range since 2019.
SNDK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11B | +378% |
| Q2 2026 | $9B | +372% |
| Q1 2026 | $6B | +251% |
| Q4 2025 | $3B | +61% |
| Q3 2025 | $2.3B | +23% |
| Q2 2025 | $1.9B | +8% |
| Q1 2025 | $1.7B | -0.6% |
| Q4 2024 | $1.9B | +13% |
SNDK has the edge over BMBL on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 80% | +72 points |
| Q2 2026 | 78% | +78 points |
| Q1 2026 | 69% | +180 points |
| Q4 2025 | 35% | +25 points |
| Q3 2025 | 7.6% | -9 points |
| Q2 2025 | 0.9% | N/A |
| Q1 2025 | -111% | -122 points |
| Q4 2024 | 10% | +6.6 points |
SNDK has the edge over BMBL on profitability, with a higher operating margin.
BMBL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $56M | -27% |
| Q2 2026 | $53.6M | -25% |
| Q1 2026 | $77.2M | +79% |
| Q4 2025 | $59.1M | +$64.5M |
| Q3 2025 | $76.8M | -18% |
| Q2 2025 | $71.2M | +116% |
| Q1 2025 | $43.2M | +1687% |
| Q4 2024 | -$5.4M | -109% |
BMBL generated $246M in free cash flow over the past year, up 32% from the year before.
SNDK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.3B | +1340% |
| Q2 2026 | $7.1B | +14355% |
| Q1 2026 | $3B | +$3B |
| Q3 2025 | $438M | +$636M |
| Q2 2025 | $49M | +$217M |
| Q1 2025 | -$18M | +$23M |
| Q3 2024 | -$198M | -$157M |
SNDK has the edge over BMBL on cash flow, with more consistent year-over-year improvement.
BMBL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.1% | +1.4M shares |
| 1 year | +28% | +28.9M shares |
| 3 years | +0.4% | +497K shares |
| 5 years | +19% | +20.7M shares |
BMBL has 132M diluted shares, up 28% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $28.7M |
| Q4 2024 | $40.3M |
BMBL hasn't bought back shares in the past year.
SNDK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -1M shares |
| 1 year | +3.4% | +5M shares |
| 3 years | +6.9% | +10M shares |
SNDK has the edge over BMBL on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5B |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
BMBL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2024 | 1.7x | Healthy |
| Q1 2024 | 2.2x | Moderate |
| Q4 2023 | 2.2x | Moderate |
| Q3 2022 | 1.9x | Healthy |
| Q2 2022 | 2.6x | Moderate |
| Q1 2022 | 3.0x | Elevated |
| Q4 2020 | 9.0x | High |
| Q3 2020 | 4.2x | High |
BMBL's net debt is about 1.7 years of its operating earnings (EBITDA), down from 2.6 years a year ago.
SNDK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
SNDK has more cash than debt.
BMBL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 77.0 | Overbought |
| Stochastic | 99.3 | Overbought |
BMBL's weekly RSI is 77 (overbought) and its Stochastic is 99 (overbought).
SNDK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.2 | Neutral |
| Stochastic | 10.6 | Oversold |
SNDK's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).
BMBL PE vs Technology Sector
| Metric | BMBL | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
BMBL has no meaningful PE right now: it lost money over the past year.
SNDK PE vs Technology Sector
| Metric | SNDK | Sector median | Relative |
|---|---|---|---|
| PE | 7.5x | 28x | 73% below |
| PE % | 4 | 27 | 23 pts below |
SNDK is trading at 7.5x earnings, a 73% discount to the Technology sector's median of 28x, though its earnings don't support one.
BMBL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.70 | 28% above |
| 20 week MA | $3.61 | 66% above |
| 50 week MA | $3.47 | 73% above |
| 100 week MA | $4.71 | 28% above |
| 200 week MA | $9.16 | 34% below |
BMBL has stronger trend alignment. BMBL is above 4 of 5 weekly averages versus SNDK above 0 of 3.
SNDK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,317.5 | 29% below |
| 20 week MA | $1,465.4 | 36% below |
| 50 week MA | $1,119.6 | 16% below |
SNDK is in a downtrend: it's below all three of its weekly moving averages, and 16% below its 50-week average.
BMBL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $75.5 | $34.9 | -54% |
| 2022 | $34.9 | $20.9 | -40% |
| 2023 | $20.9 | $14.7 | -30% |
| 2024 | $14.7 | $8.02 | -46% |
| 2025 | $8.02 | $3.52 | -56% |
| 2026 YTD | $3.52 | $6.01 | +71% |
BMBL has finished every year since 2021 lower, and it's up 71% so far in 2026.
SNDK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $50.4 | $250.1 | +396% |
| 2026 YTD | $250.1 | $937.5 | +275% |
SNDK has the edge over BMBL on returns for 2026, with the stronger performance.